U.S. Tendon Repair Market Size, Share & Trends Analysis Report By Application (Bicep Tenodesis, Rotator Cuff Repair), By Product Type (Implants, Suture Anchor Devices), And Segment- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The U.S. tendon repair market size was estimated at USD 706.8 million in 2022 and is expected to hit around USD 1,470.35 million by 2032, poised to reach at a notable CAGR of 7.6% during the forecast period 2023 to 2032.

Key Takeaways:

• The rotator cuff repair segment held the largest share of the U.S. tendon repair market in 2022 owing to the rising prevalence of sports-related injuries and the geriatric population
• The implants segment is anticipated to grow at the fastest CAGR over the forecast period, attributed to the faster recovery and less compatible issues associated with implants
• Suture anchor devices segment accounted for a significant market share in 2022 due to the higher strength of suture anchor devices
• Major buyers in the market include hospitals, primary care facilities, and surgery centers

U.S. Tendon Repair Market Report Scope

The growth is attributed to the increasing target population, the rising incidence rate of sports-related injuries, and advancements in sports medicine. Moreover, the growing improvement in technologies used for tendon and ligament repair is further propelling the growth of the overall market. New and improved versions of existing technologies have been developed by forerunners in the industry to improve surgical outcomes and achieve longevity of the surgical procedure.

The COVID-19 pandemic posed multiple challenges for U.S. healthcare services. Many industries across the nation faced or are still facing supply chain disruptions and issues with the sales of products owing to the effects of the pandemic such as lockdowns & postponement or cancellations of surgical procedures. The pandemic negatively impacted the market’s growth and resulted in a reduction in surgical activity to minimize nosocomial contamination. Due to the COVID-19 pandemic, many hospitals imposed restrictions on non-essential surgical procedures. In March 2020, the CDC and American College of Surgeons (ACS) recommended canceling or delaying non-emergency surgical procedures. This action, while significant for social safety, greatly impacted millions.

Moreover, the rising adoption of orthopedic robotic platforms in hospitals further accelerated market expansion. For instance, in March 2022, SRV Hospital, with Lokmanya Hospital, Launched a new center for excellence in robotic orthopedics. The newly launched center is equipped with Smith+Nephew’s handheld robotic device for knee surgeries. In addition, several key players such as Smith & Nephew, Stryker, & DePuy Synthes are shifting focus and developing robotic surgery. For instance, in October 2022, THINK Surgical, a leader in orthopedic surgical robots, announced that KDB investment Global Healthcare Korea invested USD 100 million in THINK Surgical to allow the faster launch of novel products.

Furthermore, technologies used in orthopedic surgery, especially for tendon and ligament repair, have been continuously improving. Manufacturers in the industry are constantly focusing on developing new and improved versions of existing technologies and improving surgical consequences to achieve durability of the surgical procedure.New technologies such as tissue grafting, the use of scaffolds, and other tissue matrices for the regeneration of native tissue are being successfully used to impart greater mobility & flexibility to the repaired limb.

However, one of the major factors restraining the growth of the market is the preference for alternative treatment.Nonsurgical treatments are often preferred due to them being less invasive and cost-effective. Treatments like oral Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) have been in use for decades as a first-line treatment for tendinopathy. Moreover, surgical intervention for tendon ruptures and tears is costlier and requires more recovery time, which may further impede the market growth.

Application Insights

The rotator cuff repair segment held the largest revenue share inU.S. tendon repair in 2022 and is anticipated to grow at a steady pace over the forecast period. The dominance of the segment is attributed to an increase in physical activity among children and adults, an increase in interest in professional sports, and an increase in the number of athletes who require foot and ankle tendon repair.

The introduction of newer cuff rotator procedures is expected to facilitate surgery rates, thereby reducing invasion and time for surgeries. For instance, in February 2022, UAB Orthopedics introduced a newer approach to rotator cuff repair through the launch of a subacromial balloon spacer procedure. With this procedure, patients can safely rehabilitate their shoulders with the help of physical therapy.

The Achilles tendinosis repair segment is expected to show the fastest CAGR over the forecast period. The Achilles tendon has become a major concern for athletes and other active individuals with chronic conditions. Thus, managing and repairing this condition is important to avoid further complications like tendon rupture and chronic pain.Healthcare organizations, hospitals, and manufacturers in the tendon repair market are taking collaborative measures to tackle the situation.

For instance, in October 2022, physiatrists in the Department of Rehabilitation Medicine and surgeons at HHS at Weill Cornell Medicine collaborated to manage Achilles tendinopathies, offering proper diagnosis and surgical & nonsurgical treatment options for tackling this condition. In addition, in March 2022, Acumed LLC with the use of Acu-Sinch Knotless technology launched Ankle Syndesmosis Repair System.

Product Type Insights

The suture anchor devices segment captured the largest revenue share in the U.S. tendon repair market in 2022 and is projected to exhibit a lucrative CAGR throughout the forecast period. The dominance of the segment is due to the increasing use of anchor devices in tendon repair surgeries. They are a primary choice in arthroscopy procedures due to their higher strength possessed by them.

Suture anchors can be knotless or knotted based on the type of injury it is being used for. Moreover, key players are focusing on developing sutures to provide better surgical procedures to the target population. For instance, in September 2022, Mesh Suture, Inc. received FDA approval for a non-absorbable polypropylene mesh suture, which can be used for soft tissues including tendons, ligaments, fascia, and muscles.

The implants segment is expected to show the fastest growth rate over the forecast period. The growth of the tendon implants market is due to an increase in the number of sports injuries and a rise in the geriatric population.Implants are routinely preferred over allografts and autografts because the use of implants is usually associated with faster recovery time, lesser compatibility issues, and reduced surgical procedure time.

Moreover, the increasing demand for tendon repair techniques is further propelling the need for the introduction and development of newer products by key manufacturing with high mechanical capabilities. In January 2023, Arthrex, Inc. received FDA approval for an ACL TightRope implant, used in the surgical treatment of orthopedic injuries for pediatric use.Furthermore, the increasing research on tendon repair techniques and solutions has also made them more accessible to patients.

Key Companies & Market Share Insights

The key players operating in the field of tendon repair technologies are constantly focusing on introducing and changing existing product lines that enhance patient outcomes and substantially increase the efficiency and effectiveness of healthcare in the U.S. For instance, in March 2023, Smith+Nephew launched the UltraTRAC QUAD ACL Reconstruction Technique consisting of the X-WING Graft Preparation System, a family of ULTRABUTTON Adjustable Fixation Devices, and QUADTRAC Quadriceps Tendon Harvest Guide System. With this launch, the company expects to expand its ability to surgeons’ graft preferences. Some prominent players in the U.S. tendon repair market include:

• Stryker
• Arthrex, Inc.
• CONMED Corporation
• Integra LifeSciences
• Smith+Nephew
• TendoMend
• Alafair Biosciences
• MIMEDX Group, Inc.

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S. Tendon Repair market.

By Application 

• Rotator Cuff Repair
• Achilles Tendinosis Repair
• Cruciate Ligament Repair
• Bicep Tenodesis
• Others

By Product Type 

• Implants
• Suture Anchor Devices
• Grafts
• Matrix/Scaffolds
  • Tendon Repair
  • Tendon Protection Matrix/Scaffolds
• Screws
• Others